46 F
New York
Tuesday, October 4, 2022



MEDraysintell Publishes the 9th Edition of Its Nuclear Medicine Report & Directory

Related Articles

Louvain-la-Neuve, Belgium, September 16, 2022 –(PR.com)– MEDraysintell releases the 9th. Edition of the Nuclear Medicine Report and Directory-2022, a set of three volumes aiming to provide a comprehensive and exhaustive review of the worldwide nuclear medicine landscape. A thorough analysis of the existing marketed products, the evaluation of an exhaustive list of radiopharmaceuticals under clinical or early stage development and the description of all associated companies active in this field are provided in full details.

This new Edition-2022 provides over nearly 3,500 pages a description of 970 products, together with a comprehensive profile of 380 companies active around the world in the radiopharmaceutical industry. The number of direct web links to bibliographical references was increased to above 3,100.
– MEDraysintell Nuclear Medicine (Part 1) – Marketed Radiopharmaceuticals
– MEDraysintell Nuclear Medicine (Part 2) -…

Read more…

Popular Articles